HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021)
HUTCHMED (China) (HCM) reported Cash from Investing Activities of -$315.9 million for Q2 2021, down 665.3% year-over-year from $55.9 million in Q2 2020, and down 297.41% quarter-over-quarter from $160.0 million in Q1 2021.
HUTCHMED (China) (HCM) Cash from Investing Activities (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has 4 years of Cash from Investing Activities data on file, last reported at -$315.9 million in Q2 2021.
- Cash from Investing Activities for Q2 2021 came in at -$315.9 million, down 665.3% year-over-year; the trailing twelve-month figure through Jun 2021 was -$295.0 million (down 281.98% YoY), and the FY2025 annual result was -$29.4 million, up 69.38% from the prior year.
- Cash from Investing Activities slipped to -$315.9 million in Q2 2021 per HCM's latest filing, from $160.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $160.0 million in Q1 2021 and troughed at -$315.9 million in Q2 2021.
- A 4-year average of -$11.0 million and a median of $19.0 million in 2019 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2019 and 2021: Cash from Investing Activities surged 299.29% in 2019, then tumbled 665.3% in 2021.
- A 4-year view of Cash from Investing Activities shows it stood at -$15.3 million in 2018, then soared by 193.2% to $14.2 million in 2019, then sank by 390.3% to -$41.3 million in 2020, then plunged by 665.3% to -$315.9 million in 2021.
- Business Quant data shows HCM's Cash from Investing Activities at -$315.9 million in Q2 2021, $160.0 million in Q1 2021, and -$41.3 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 25.99 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -15.45 Mn |
| 10 | HUTCHMED (China) | 1.20 Bn | -269.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -315.92 Mn |
| Jun 30, 2021 | -315.92 Mn |
| Mar 31, 2021 | 160.04 Mn |
| Mar 31, 2021 | 160.04 Mn |
| Jun 30, 2020 | -41.28 Mn |
| Jun 30, 2020 | -41.28 Mn |
| Mar 31, 2020 | -97.84 Mn |
| Mar 31, 2020 | -97.84 Mn |
| Dec 31, 2019 | 14.22 Mn |
| Dec 31, 2019 | 14.22 Mn |
| Sep 30, 2019 | 47.67 Mn |
| Sep 30, 2019 | 47.67 Mn |
| Jun 30, 2019 | 23.76 Mn |
| Jun 30, 2019 | 23.76 Mn |
| Mar 31, 2019 | 33.38 Mn |
| Mar 31, 2019 | 33.38 Mn |
| Dec 31, 2018 | -15.26 Mn |
| Dec 31, 2018 | -15.26 Mn |
| Sep 30, 2018 | 43.22 Mn |
| Sep 30, 2018 | 43.22 Mn |